Considering only the 115 patients without ACC and aggressive neuroendocrine neoplasms (66 CD, 9 ECS, 40 CPA), HCT (38.7%), Hb (13 g/dl), and RBC (4.2 n*106/μl) increased in ECS, but all three were still significantly lower than in their CD counterparty (always p < 0.005). The gene discussed is GSTM1; the disease is neuroendocrine neoplasm.